Patent · US Active

Sphingosine kinase Type 1 inhibitors and uses thereof

US11737992B2 · kind B2 · utility

0Cited by

10References

10Claims

0Family size

Assignees

ENZO THERAPEUTICS, INC. · US
Virginia Commonwealth University · US

Inventors

Sarah Spiegel · Richmond, US
Robert Elliot Zipkin · Wynnebrook Manor, US
Jeffrey Kroll Adams · Fort Washington, US

Key dates

Filing date	Feb 8, 2021
Grant date	Aug 29, 2023
Priority date	—
Expiry date	Sep 7, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D295/092
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are inhibitors of sphingosine kinase Type I that are useful in the treatment of neuropathic pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.